<ѻý>UNMC Mourns Surgeon Killed in Plane Crashѻý> James Edney, former chief of the division of surgical oncology, was piloting the small aircraft Aug 09, 2021
<ѻý>A Patient Care App Diagnosed Me With Cancerѻý> No one should receive a serious diagnosis this way -- not even a doctor like myself Jul 16, 2021
<ѻý>Keytruda Before, After Surgery Improves Outcome in TNBCѻý> Results from KEYNOTE-522 show "practice-changing" impact on EFS Jul 15, 2021
<ѻý>Raise a Glass? Study Tallies Cancer Cases From Boozeѻý> Heavy drinking habits accounted for about half of new alcohol-associated cases Jul 13, 2021
<ѻý>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survivalѻý> News, features, and commentary about cancer-related issues Jun 16, 2021
<ѻý>COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care?ѻý> News, features, and commentary about cancer-related issues Jun 10, 2021
<ѻý>Bispecific Antibody Active in NRG1-Positive Pancreatic Cancerѻý> Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors Jun 10, 2021
<ѻý>More Support for Gene Assay to Guide Breast Cancer Treatmentѻý> More nuanced data on treatment de-escalation, extended endocrine therapy Jun 09, 2021
<ѻý>Novel CDK 4/6 Inhibitor Proves Mettle in HR+/HER2- Advanced Breast Cancerѻý> Dalpiciclib may be a new treatment option; palbociclib and ribociclib continue to shine Jun 06, 2021
<ѻý>Olaparib Wins in Early BRCA-Mutant Breast Cancerѻý> First trial to show adjuvant PARP inhibitor benefit inBRCA mutation carriers Jun 03, 2021
<ѻý>Lymph Node Findings on PET: Cancer or COVID Vaccine?ѻý> Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<ѻý>RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancersѻý> Responses to selpercatinib in almost half of tumors outside approved indications May 21, 2021
<ѻý>Breast Cancer and MS: New Data Shed Light on Survivalѻý> Study compares breast cancer patients with and without MS May 19, 2021
<ѻý>A Call for Nuance in Cardioprotection With Early Breast Cancer Therapyѻý> Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
<ѻý>Impressive Disease Control in Metastatic Triple-Negative Breast Cancerѻý> ESMO Breast: Reassuring safety data for dual anti-HER2 therapy, antibody-drug conjugate May 14, 2021
<ѻý>Chemo-Free Regimen Shows Promise in High-Risk Early Breast Cancerѻý> PFS and other outcomes with letrozole-palbociclib almost identical to chemotherapy May 12, 2021
<ѻý>SBRT Safe for Cancer Patients With Multiple Metastasesѻý> Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
<ѻý>New Clues to Sleep Problems, Solutions in Cancer Patientsѻý> Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
<ѻý>Healthy Lifestyle May Mitigate Heart Risks for Young Cancer Survivorsѻý> Literature reviews find particularly persistent cardiovascular complications in these patients Apr 28, 2021
<ѻý>Chemotherapy Nausea Linked to Stress, Neuropsych Symptomsѻý> High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
<ѻý>Auricular Acupressure May Relieve Neuropathy in Breast Cancerѻý> First randomized trial of the noninvasive technique in such patients Apr 22, 2021
<ѻý>Are Post-Mastectomy Lymphedema Precautions Needed for All?ѻý> Standard risk reduction efforts may not decrease incidence, researchers say Apr 21, 2021
<ѻý>Triple-Negative Breast Cancers Not All the Sameѻý> Histology tied to treatment response, outcomes Apr 12, 2021
<ѻý>Safety Reassurance for Major Class of Diabetes Drugsѻý> Pooled trial data show no link to breast cancer Mar 24, 2021
<ѻý>Time to Revisit Distant Nodal Status in Breast Cancer Curability?ѻý> Comparable survival for distant and regional nodal involvement, when treated similarly Mar 16, 2021
<ѻý>PD-1 Inhibitor Falls Short in Triple-Negative Breast Cancerѻý> No survival benefit with pembrolizumab vs chemotherapy in second-, third-line treatment Mar 08, 2021
<ѻý>New Targeted Therapies Show Promise in Cancerѻý> Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
<ѻý>Mammo Study: One Saves Lives, More Exams Save More Livesѻý> Risk of fatal breast cancer decreases with increasing participation in screening Mar 02, 2021
<ѻý>FDA Panel Slows the Roll for Pembrolizumab in Breast Cancerѻý> Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
<ѻý>Has Pembrolizumab Finally Met an Indication FDA Doesn't Like?ѻý> Agency staff skeptical of data in early breast cancer Feb 08, 2021
<ѻý>Optimizing Neoadjuvant Therapy for Breast Cancerѻý> ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
<ѻý>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemoѻý> News, features, and commentary about cancer-related issues Jan 21, 2021
<ѻý>Oncotype DX Misses on Breast Cancer Risk in Black Womenѻý> Accuracy of 21-gene recurrence score worse compared with white women Jan 21, 2021
<ѻý>Not Just BRCA: Large Studies ID Other Key Breast Cancer Risk Genesѻý> Implications for screening and other risk-management strategies, researchers say Jan 20, 2021
<ѻý>Most Women Satisfied With 'Going Flat' After Mastectomyѻý> Lack of surgeon support key factor in later dissatisfaction, study shows Jan 08, 2021
<ѻý>PARP Inhibitors Linked With Blood Cancer Riskѻý> Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<ѻý>Add-On HDAC Inhibitor No Help in Breast Cancerѻý> PFS, OS similar to endocrine therapy alone for advanced HR+ disease Dec 15, 2020
<ѻý>Broader Role for PARP Inhibitors in Breast Cancer?ѻý> Responses in tumors with somatic or germline mutations related to HRD Dec 14, 2020
<ѻý>Online Tool Refines Individual Risks in Breast Cancerѻý> RSClin incorporates 21-gene recurrence score with tumor grade, size, and more Dec 13, 2020